Section 335.9120  Training for Ophthalmic Use of Strontium-90

Except as provided in Section 335.9160, the licensee shall require the authorized user using only strontium-90 for ophthalmic radiation therapy to be a physician who:

a)         Is an authorized user who meets the requirements of Section 335.9100 or equivalent U.S. Nuclear Regulatory Commission or Agreement State requirements; or

b)         Has obtained the attestation described in subsection (c)of this Section and has:

1)         Completed 24 hours of classroom and laboratory training applicable to the use of strontium-90 for ophthalmic radiation therapy.  The training shall include:

A)        Radiation physics and instrumentation;

B)        Radiation protection;

C)        Mathematics pertaining to the use and measurement of radioactivity;

D)        Radiation biology; and

2)         Completed clinical training in ophthalmic radiation therapy under the supervision of an authorized user at a medical institution that includes the use of strontium-90 for the ophthalmic treatment of 5 patients.  The supervised clinical training shall include:

A)        Examination of each patient to be treated;

B)        Calculation of the dose to be administered;

C)        Administration of the dose;

D)        Follow-up and review of each patient's case history.

c)         Has obtained written attestation that the individual has satisfactorily completed the requirements in subsection (b) of this Section and has achieved a level of competency sufficient to function independently as an authorized user of strontium-90 for ophthalmic use.  The attestation shall be signed by a preceptor authorized user who meets the requirements in this Section, Section 335.9100, 335.9160 or equivalent U.S. Nuclear Regulatory Commission or Agreement State requirements.

(Source:  Amended at 35 Ill. Reg. 884, effective December 30, 2010)